Merck and Eisai collaborate to develop and sell Eisai cancer drug
Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima,...
Sanofi, DNDi Seek EMA Review For Sleeping Sickness Drug
The Paris, France-based drugmaker said it is hoped that the treatment will contribute to the elimination of the disease.
The European Medicines Agency has accepted...
Alexion Appoints Judith A. Reinsdorf, J.D., To Its Board Of Directors
Alexion Pharmaceuticals, Inc. announced that Judith A. Reinsdorf, J.D., has been appointed to the Company’s Board of Directors. Ms. Reinsdorf is an accomplished executive...
MRSA infections can be protected by Immune system: Research
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered...
Novartis compound to fight Alzheimer’s disease shows potential.
Novartis Compound designed to fight Alzheimer’s disease shows positive signs in the lab. The molecule is restoring the activity of neurons and neural circuits...
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
MacroGenics, Inc. a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced presentation of data...
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the appointment of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...